| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.979 | 0.004 | 0.979 | Analgesic | 0.921 0.004 CID_154699733 | ||
| 0.941 | 0.002 | 0.941 | Analgesic, opioid | 0.787 0.002 CID_154699733 | ||
| 0.917 | 0.003 | 0.939 | Psychostimulant | 0.939 0.002 CID_154699733 | CID_154699733 | |
| 0.867 | 0.002 | 0.867 | Opioid agonist | 0.719 0.003 CID_154699733 | ||
| 0.86 | 0.002 | 0.86 | Opioid antagonist | 0.767 0.003 CID_154699733 | ||
| 0.855 | 0.004 | 0.872 | Spasmolytic | 0.872 0.004 CID_154699733 | CID_154699733 | |
| 0.844 | 0.001 | 0.844 | Opioid mu receptor antagonist | 0.728 0.002 CID_154699733 | ||
| 0.835 | 0.001 | 0.835 | Opioid mu receptor agonist | 0.67 0.002 CID_154699733 | ||
| 0.789 | 0.002 | 0.789 | Opioid delta receptor antagonist | 0.677 0.003 CID_154699733 | ||
| 0.777 | 0.003 | 0.777 | Anesthetic general | 0.666 0.004 CID_154699733 | ||
| 0.773 | 0.001 | 0.773 | Opioid kappa receptor antagonist | 0.644 0.002 CID_154699733 | ||
| 0.738 | 0.002 | 0.738 | Opioid delta receptor agonist | 0.526 0.003 CID_154699733 | ||
| 0.736 | 0.005 | 0.736 | 5 Hydroxytryptamine release stimulant | 0.671 0.009 CID_154699733 | ||
| 0.661 | 0.001 | 0.661 | Opioid kappa receptor agonist | 0.453 0.002 CID_154699733 | ||
| 0.656 | 0.003 | 0.656 | Sigma receptor agonist | 0.551 0.006 CID_154699733 | ||
| 0.645 | 0.004 | 0.645 | Sigma receptor antagonist | 0.139 0.012 CID_154699733 | ||
| 0.619 | 0.004 | 0.619 | Antipruritic | 0.329 0.01 CID_154699733 | ||
| 0.561 | 0.004 | 0.561 | Alpha 2 adrenoreceptor antagonist | |||
| 0.552 | 0.004 | 0.552 | Alpha 2a adrenoreceptor antagonist | |||
| 0.519 | 0.041 | 0.789 | Transcription factor NF kappa B inhibitor | 0.789 0.014 CID_154699733 | CID_154699733 | |
| 0.478 | 0.004 | 0.478 | Acetylcholine M1 receptor antagonist | 0.163 0.063 CID_154699733 | ||
| 0.442 | 0.002 | 0.442 | Toll-Like receptor 4 antagonist | 0.379 0.003 CID_154699733 | ||
| 0.431 | 0.004 | 0.431 | Toll-Like receptor antagonist | 0.156 0.052 CID_154699733 | ||
| 0.452 | 0.046 | 0.517 | Immunosuppressant | 0.517 0.029 CID_154699733 | CID_154699733 | |
| 0.4 | 0.008 | 0.4 | Cholinergic antagonist | |||
| 0.39 | 0.008 | 0.39 | Acetylcholine antagonist | |||
| 0.476 | 0.098 | 0.741 | Antiinflammatory | 0.741 0.024 CID_154699733 | CID_154699733 | |
| 0.382 | 0.038 | 0.631 | Antioxidant | 0.631 0.009 CID_154699733 | CID_154699733 | |
| 0.343 | 0.033 | 0.47 | Nitric oxide antagonist | 0.47 0.018 CID_154699733 | CID_154699733 | |
| 0.336 | 0.042 | 0.552 | Free radical scavenger | 0.552 0.012 CID_154699733 | CID_154699733 | |
| 0.362 | 0.069 | 0.362 | Vasodilator, peripheral | 0.292 0.101 CID_154699733 | ||
| 0.322 | 0.035 | 0.322 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.302 | 0.029 | 0.448 | Hepatoprotectant | 0.448 0.01 CID_154699733 | CID_154699733 | |
| 0.277 | 0.022 | 0.277 | Cholinergic | 0.127 0.099 CID_154699733 | ||
| 0.265 | 0.012 | 0.265 | Acetylcholine muscarinic antagonist | |||
| 0.283 | 0.032 | 0.283 | P-glycoprotein inhibitor | 0.231 0.048 CID_154699733 | ||
| 0.302 | 0.052 | 0.609 | Hypoglycemic | 0.609 0.008 CID_154699733 | CID_154699733 | |
| 0.252 | 0.004 | 0.252 | Prolactin inhibitor | |||
| 0.251 | 0.007 | 0.251 | Dopamine agonist | 0.099 0.028 CID_154699733 | ||
| 0.306 | 0.063 | 0.306 | Hypoxia-inducible factor 1 alpha inhibitor | 0.269 0.084 CID_154699733 | ||
| 0.361 | 0.133 | 0.511 | Apoptosis agonist | 0.511 0.071 CID_154699733 | CID_154699733 | |
| 0.302 | 0.077 | 0.302 | Sodium/bile acid cotransporter inhibitor | |||
| 0.235 | 0.01 | 0.235 | Acetylcholine nicotinic antagonist | |||
| 0.245 | 0.021 | 0.245 | Alpha adrenoreceptor antagonist | |||
| 0.219 | 0.005 | 0.219 | Dopamine D2 agonist | 0.13 0.008 CID_154699733 | ||
| 0.264 | 0.062 | 0.343 | Vasodilator | 0.343 0.035 CID_154699733 | CID_154699733 | |
| 0.212 | 0.018 | 0.519 | Expectorant | 0.519 0.003 CID_154699733 | CID_154699733 | |
| 0.197 | 0.019 | 0.197 | Nav1.1 sodium channel blocker | |||
| 0.275 | 0.104 | 0.386 | Apoptosis antagonist | 0.386 0.042 CID_154699733 | CID_154699733 | |
| 0.217 | 0.047 | 0.217 | Lipocortins synthesis antagonist | 0.171 0.079 CID_154699733 | ||
| 0.187 | 0.017 | 0.187 | Antineoplastic alkaloid | 0.086 0.058 CID_154699733 | ||
| 0.261 | 0.092 | 0.477 | Immunostimulant | 0.477 0.032 CID_154699733 | CID_154699733 | |
| 0.201 | 0.033 | 0.201 | Acetylcholinesterase inhibitor | |||
| 0.266 | 0.099 | 0.266 | Caspase 3 stimulant | 0.247 0.115 CID_154699733 | ||
| 0.204 | 0.038 | 0.236 | Interleukin 6 antagonist | 0.236 0.026 CID_154699733 | CID_154699733 | |
| 0.16 | 0.015 | 0.16 | Acetylcholine M3 receptor agonist | 0.088 0.053 CID_154699733 | ||
| 0.157 | 0.012 | 0.157 | Neuronal nicotinic receptor antagonist | |||
| 0.136 | 0.003 | 0.136 | Prolactin release inhibitor | 0.103 0.004 CID_154699733 | ||
| 0.155 | 0.022 | 0.155 | Breast cancer-resistant protein inhibitor | |||
| 0.161 | 0.033 | 0.161 | Antiadrenergic | |||
| 0.178 | 0.051 | 0.25 | Lipid peroxidase inhibitor | 0.25 0.027 CID_154699733 | CID_154699733 | |
| 0.138 | 0.013 | 0.138 | Alpha 2d adrenoreceptor antagonist | 0.098 0.053 CID_154699733 | ||
| 0.268 | 0.143 | 0.468 | Histamine release inhibitor | 0.468 0.042 CID_154699733 | CID_154699733 | |
| 0.176 | 0.052 | 0.276 | Protein kinase stimulant | 0.276 0.02 CID_154699733 | CID_154699733 | |
| 0.155 | 0.03 | 0.155 | Alpha 2c adrenoreceptor antagonist | |||
| 0.138 | 0.017 | 0.138 | Dopamine D1 antagonist | |||
| 0.214 | 0.097 | 0.214 | Aldehyde oxidase inhibitor | |||
| 0.243 | 0.127 | 0.376 | Interleukin 2 agonist | 0.376 0.035 CID_154699733 | CID_154699733 | |
| 0.124 | 0.011 | 0.124 | Glycine receptor agonist | 0.09 0.028 CID_154699733 | ||
| 0.12 | 0.008 | 0.12 | Dopamine D5 antagonist | |||
| 0.168 | 0.057 | 0.425 | NOS3 expression enhancer | 0.425 0.007 CID_154699733 | CID_154699733 | |
| 0.157 | 0.046 | 0.162 | DNA polymerase I inhibitor | 0.162 0.043 CID_154699733 | CID_154699733 | |
| 0.302 | 0.192 | 0.302 | Caspase 9 stimulant | 0.285 0.211 CID_154699733 | ||
| 0.115 | 0.005 | 0.115 | Nociceptin (N/OFQ) receptor antagonist | |||
| 0.148 | 0.049 | 0.338 | Cyclooxygenase 3 inhibitor | 0.338 0.005 CID_154699733 | CID_154699733 | |
| 0.186 | 0.091 | 0.187 | Neurotrophic factor enhancer | 0.187 0.09 CID_154699733 | CID_154699733 | |
| 0.125 | 0.037 | 0.125 | Creatine kinase inhibitor | |||
| 0.14 | 0.052 | 0.14 | Adenylate cyclase inhibitor | |||
| 0.241 | 0.158 | 0.241 | Calcium channel activator | |||
| 0.122 | 0.043 | 0.122 | Adrenaline antagonist | |||
| 0.142 | 0.065 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.131 0.115 CID_154699733 | ||
| 0.124 | 0.049 | 0.124 | Estrogen antagonist | |||
| 0.103 | 0.03 | 0.126 | Glycine receptor antagonist | 0.126 0.015 CID_154699733 | CID_154699733 | |
| 0.138 | 0.065 | 0.138 | Nav1.2 sodium channel blocker | |||
| 0.071 | 0.003 | 0.071 | NMDA receptor phencyclidine site antagonist | |||
| 0.111 | 0.045 | 0.111 | Estrogen receptor beta antagonist | |||
| 0.2 | 0.136 | 0.2 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.104 | 0.044 | 0.104 | Acetylcholine agonist | |||
| 0.118 | 0.06 | 0.118 | Alpha 2b adrenoreceptor antagonist | |||
| 0.1 | 0.047 | 0.1 | Androgen antagonist | |||
| 0.093 | 0.041 | 0.093 | Dopamine antagonist | |||
| 0.063 | 0.011 | 0.063 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.078 | 0.026 | 0.078 | Dopamine uptake inhibitor | |||
| 0.069 | 0.02 | 0.069 | Acetylcholine M2 receptor agonist | |||
| 0.086 | 0.037 | 0.086 | Dopamine D2 antagonist | |||
| 0.053 | 0.004 | 0.053 | Dopamine D1 agonist | 0.046 0.005 CID_154699733 | ||
| 0.142 | 0.094 | 0.142 | Growth hormone agonist | |||
| 0.118 | 0.072 | 0.118 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.093 | 0.049 | 0.189 | Antineoplastic antibiotic | 0.189 0.023 CID_154699733 | CID_154699733 | |
| 0.065 | 0.024 | 0.065 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.107 | 0.068 | 0.107 | Electron transport complex I inhibitor | |||
| 0.222 | 0.185 | 0.342 | Antiobesity | 0.342 0.091 CID_154699733 | CID_154699733 | |
| 0.056 | 0.025 | 0.056 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.036 | 0.008 | 0.036 | Nociceptin (N/OFQ) receptor agonist | |||
| 0.055 | 0.028 | 0.055 | Dopamine transporter inhibitor | |||
| 0.078 | 0.052 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.098 0.034 CID_154699733 | CID_154699733 | |
| 0.133 | 0.108 | 0.155 | Melanin inhibitor | 0.155 0.075 CID_154699733 | CID_154699733 | |
| 0.064 | 0.039 | 0.064 | NMDA 2C receptor antagonist | |||
| 0.058 | 0.041 | 0.064 | Lipocortins synthesis agonist | 0.064 0.029 CID_154699733 | CID_154699733 | |
| 0.059 | 0.046 | 0.059 | Adrenaline uptake inhibitor | |||
| 0.049 | 0.036 | 0.049 | Estrogen agonist | |||
| 0.079 | 0.067 | 0.079 | CC chemokine 5 receptor agonist | |||
| 0.09 | 0.079 | 0.09 | Anabolic | |||
| 0.042 | 0.032 | 0.042 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.041 | 0.032 | 0.041 | Acetylcholine M1 receptor agonist | |||
| 0.044 | 0.036 | 0.044 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.03 | 0.022 | 0.03 | Acetylcholine M4 receptor agonist | |||
| 0.028 | 0.022 | 0.028 | RNA-directed RNA polymerase stimulant | |||
| 0.029 | 0.024 | 0.029 | Estrogen receptor beta agonist | |||
| 0.123 | 0.118 | 0.123 | Adenylate cyclase stimulant | |||
| 0.049 | 0.045 | 0.049 | Acetylcholine muscarinic agonist | |||
| 0.063 | 0.059 | 0.063 | NMDA 2 receptor antagonist | |||
| 0.032 | 0.03 | 0.032 | Tubulin agonist | |||
| 0.035 | 0.034 | 0.035 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.154 | 0.183 | 0.329 | Peptidyltransferase inhibitor | 0.329 0.016 CID_154699733 | CID_154699733 | |
| 0.168 | 0.198 | 0.317 | Cholesterol antagonist | 0.317 0.081 CID_154699733 | CID_154699733 | |
| 0.026 | 0.058 | 0.059 | Antibiotic Aminoglycoside-like | 0.059 0.009 CID_154699733 | CID_154699733 | |
| 0.14 | 0.173 | 0.334 | Tumour necrosis factor alpha release inhibitor | 0.334 0.042 CID_154699733 | CID_154699733 | |
| 0.032 | 0.066 | 0.041 | Microtubule stabilization | 0.041 0.04 CID_154699733 | CID_154699733 | |
| 0.081 | 0.117 | 0.122 | Alkylator | 0.122 0.066 CID_154699733 | CID_154699733 | |
| 0.036 | 0.084 | 0.063 | Alpha-mannosidase inhibitor | 0.063 0.023 CID_154699733 | CID_154699733 | |
| 0.029 | 0.082 | 0.08 | Protein 50S ribosomal subunit inhibitor | 0.08 0.019 CID_154699733 | CID_154699733 | |
| 0.149 | 0.205 | 0.226 | DNA synthesis inhibitor | 0.226 0.087 CID_154699733 | CID_154699733 | |
| 0.208 | 0.265 | 0.658 | Cyclophilin D inhibitor | 0.658 0.019 CID_154699733 | CID_154699733 | |
| 0.013 | 0.07 | 0.028 | Protein 30S ribosomal subunit inhibitor | 0.028 0.014 CID_154699733 | CID_154699733 | |
| 0.107 | 0.17 | 0.161 | Interferon gamma antagonist | 0.161 0.066 CID_154699733 | CID_154699733 | |
| 0.071 | 0.136 | 0.134 | AMP-activated protein kinase stimulant | 0.134 0.039 CID_154699733 | CID_154699733 | |
| 0.162 | 0.232 | 0.482 | Antithrombotic | 0.482 0.032 CID_154699733 | CID_154699733 | |
| 0.009 | 0.08 | 0.045 | Arginase inhibitor | 0.045 0.018 CID_154699733 | CID_154699733 | |
| 0.01 | 0.086 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 CID_154699733 | CID_154699733 | |
| 0.013 | 0.094 | 0.025 | Sodium/glucose cotransporter inhibitor | 0.025 0.018 CID_154699733 | CID_154699733 | |
| 0.087 | 0.171 | 0.172 | Diuretic | 0.172 0.059 CID_154699733 | CID_154699733 | |
| 0.021 | 0.11 | 0.048 | Mannosidase inhibitor | 0.048 0.027 CID_154699733 | CID_154699733 | |
| 0.031 | 0.121 | 0.067 | Glucose-6-phosphate translocase inhibitor | 0.067 0.018 CID_154699733 | CID_154699733 | |
| 0.065 | 0.222 | 0.47 | Angiogenesis stimulant | 0.47 0.014 CID_154699733 | CID_154699733 | |
| 0.042 | 0.21 | 0.129 | Topoisomerase II inhibitor | 0.129 0.06 CID_154699733 | CID_154699733 | |
| 0.04 | 0.22 | 0.092 | ATPase (Vacuolar H+) inhibitor | 0.092 0.052 CID_154699733 | CID_154699733 | |
| 0.09 | 0.286 | 0.176 | ATPase inhibitor | 0.176 0.063 CID_154699733 | CID_154699733 | |
| 0.088 | 0.311 | 0.168 | Cyclic AMP phosphodiesterase inhibitor | 0.168 0.125 CID_154699733 | CID_154699733 | |
| 0.062 | 0.306 | 0.178 | Interleukin agonist | 0.178 0.141 CID_154699733 | CID_154699733 | |
| 0.106 | 0.352 | 0.252 | Vasodilator, coronary | 0.252 0.133 CID_154699733 | CID_154699733 | |
| 0.025 | 0.275 | 0.114 | Topoisomerase I inhibitor | 0.114 0.06 CID_154699733 | CID_154699733 | |
| 0.039 | 0.298 | 0.099 | Amylase inhibitor | 0.099 0.098 CID_154699733 | CID_154699733 | |
| 0.013 | 0.305 | 0.026 | Toll-Like receptor 4 agonist | 0.026 0.02 CID_154699733 | CID_154699733 | |
| 0.091 | 0.391 | 0.128 | CC chemokine 6 receptor antagonist | 0.128 0.078 CID_154699733 | CID_154699733 | |
| 0.041 | 0.344 | 0.091 | Transcription factor NF kappa B stimulant | 0.091 0.049 CID_154699733 | CID_154699733 | |
| 0.089 | 0.394 | 0.318 | Immunomodulator | 0.318 0.072 CID_154699733 | CID_154699733 | |
| 0.05 | 0.374 | 0.243 | Platelet adhesion inhibitor | 0.243 0.052 CID_154699733 | CID_154699733 | |
| 0.01 | 0.351 | 0.231 | Selectin antagonist | 0.231 0.009 CID_154699733 | CID_154699733 | |
| 0.084 | 0.438 | 0.467 | Antibacterial | 0.467 0.051 CID_154699733 | CID_154699733 | |
| 0.049 | 0.413 | 0.265 | Insulin secretagoues | 0.265 0.017 CID_154699733 | CID_154699733 | |
| 0.048 | 0.417 | 0.154 | Hemostatic | 0.154 0.063 CID_154699733 | CID_154699733 | |
| 0.039 | 0.417 | 0.201 | Platelet antagonist | 0.201 0.1 CID_154699733 | CID_154699733 | |
| 0.015 | 0.611 | 0.161 | Thrombolytic | 0.161 0.074 CID_154699733 | CID_154699733 | |
| 0.012 | 0.75 | 0.116 | Cell adhesion inhibitor | 0.116 0.068 CID_154699733 | CID_154699733 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |